Pembrolizumab as post nephrectomy adjuvant therapy for patients with renal cell carcinoma - interview with Stefan N. Symeonides

from Medical Digest & Congress Report · host Medical Congress News

Professor Stefan N. Symeonides gave us a talk about the results from 30-month follow-up of KEYNOTE-564. Video: https://congressreport.eu/scientific-contents/standalonecontent:pembrolizumab-post-nephrectomy-adjuvant-therapy-patients-renal-cell-carcinoma

Episode metadata supplied by the publisher feed · Published Mar 8, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Pembrolizumab as post nephrectomy adjuvant therapy for patients with renal cell carcinoma - interview with Stefan N. Symeonides

0:00 16:33

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 16 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on March 8, 2022.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!